Cargando…
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Long term benefits following short-term administration of high psychedelic doses of serotonergic and dissociative hallucinogens, typified by psilocybin and ketamine respectively, support their potential as treatments for psychiatric conditions such as major depressive disorder. The high psychedelic...
Autores principales: | Higgins, Guy A., Carroll, Nicole K., Brown, Matt, MacMillan, Cam, Silenieks, Leo B., Thevarkunnel, Sandy, Izhakova, Julia, Magomedova, Lilia, DeLannoy, Ines, Sellers, Edward M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952974/ https://www.ncbi.nlm.nih.gov/pubmed/33716753 http://dx.doi.org/10.3389/fphar.2021.640241 |
Ejemplares similares
-
Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research
por: Higgins, Guy A., et al.
Publicado: (2020) -
Characterization of the 5-HT(2C) receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity
por: Higgins, Guy A, et al.
Publicado: (2015) -
Rediscovering Psilocybin as an Antidepressive Treatment Strategy
por: Zeiss, Rene, et al.
Publicado: (2021) -
Is psilocybin an effective antidepressant and what is its Mechanism of action?
por: Mann, J. John
Publicado: (2023) -
Psilocybin as an antidepressant strategy - a review of safety aspects
por: Zeiss, R.
Publicado: (2023)